BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 14676784)

  • 1. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.
    Porrata LF; Litzow MR; Inwards DJ; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Ansell SM; Micallef IN; Markovic SN
    Bone Marrow Transplant; 2004 Feb; 33(3):291-8. PubMed ID: 14676784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study.
    Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Litzow MR; Winters JL; Markovic SN
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):807-16. PubMed ID: 18541201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between splenic dose and radiation-induced lymphopenia.
    Ma Y; Kong Y; Zhang S; Peng Y; Xu M; Zhang J; Xu H; Hong Z; Xing P; Qian J; Zhang L
    J Radiat Res; 2024 May; ():. PubMed ID: 38718391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral lymphocyte count as an indicator of radiotherapy effectiveness in hypopharyngeal squamous cell carcinoma.
    Lin H; Gao C; Heng Y; Zhu X; Wang T; Zhou L; Zhang M; Wu C; Tao L
    Clin Otolaryngol; 2024 Apr; ():. PubMed ID: 38596906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.
    Vánky F; Klein E; Willems J; Böök K; Ivert T; Péterffy A; Nilsonne U; Kreicbergs A; Aparisi T
    Cancer Immunol Immunother; 1986; 21(1):69-76. PubMed ID: 3455878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma.
    Porrata LF; Gertz MA; Geyer SM; Litzow MR; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Lacy MQ; Dispenzieri A; Snow DS; Markovic SN
    Leukemia; 2004 Jun; 18(6):1085-92. PubMed ID: 15042106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
    Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
    Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34
    Turunen AS; Kuittinen O; Kuitunen H; Vasala K; Penttilä K; Harmanen M; Keskinen L; Mäntymaa P; Pelkonen J; Varmavuo V; Jantunen E; Partanen A
    Transfus Med Hemother; 2023 Oct; 50(5):428-437. PubMed ID: 37899989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal lymphoma: pathogenesis, diagnosis and treatment.
    Yang H; Xun Y; Ke C; Tateishi K; You H
    Mol Biomed; 2023 Sep; 4(1):29. PubMed ID: 37718386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Killer Cells Are Key Host Immune Effector Cells Affecting Survival in Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation.
    Porrata LF
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Infused Autograft Absolute Numbers of Immune Effector Cells on Survival Post-Autologous Stem Cell Transplantation.
    Porrata LF
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma.
    Merino AM; Mehta RS; Luo X; Kim H; De For T; Janakiram M; Cooley S; Wangen R; Cichocki F; Weisdorf DJ; Miller JS; Bachanova V
    Transplant Cell Ther; 2021 Apr; 27(4):310.e1-310.e6. PubMed ID: 33836870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment.
    Orrantia A; Terrén I; Astarloa-Pando G; Zenarruzabeitia O; Borrego F
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.
    Tolomelli G; Mancuso K; Tacchetti P; Patriarca F; Galli M; Pantani L; Zannetti B; Motta MR; Rizzi S; Dan E; Sinigaglia B; Giudice V; Olmo A; Arpinati M; Chirumbolo G; Fanin R; Lewis RE; Paris L; Bonifazi F; Cavo M; Curti A; Lemoli RM
    Bone Marrow Transplant; 2020 May; 55(5):946-954. PubMed ID: 31768009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.
    Andermann TM; Peled JU; Ho C; Reddy P; Riches M; Storb R; Teshima T; van den Brink MRM; Alousi A; Balderman S; Chiusolo P; Clark WB; Holler E; Howard A; Kean LS; Koh AY; McCarthy PL; McCarty JM; Mohty M; Nakamura R; Rezvani K; Segal BH; Shaw BE; Shpall EJ; Sung AD; Weber D; Whangbo J; Wingard JR; Wood WA; Perales MA; Jenq RR; Bhatt AS;
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1322-1340. PubMed ID: 29471034
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT.
    Ho CM; McCarthy PL; Wallace PK; Zhang Y; Fora A; Mellors P; Tario JD; McCarthy BLS; Chen GL; Holstein SA; Balderman SR; Cao X; Paiva B; Hahn T
    Blood Adv; 2017 Jun; 1(15):1056-1066. PubMed ID: 29296748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of autograft natural killer cell/CD14
    Kansagra A; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN; Porrata LF
    Bone Marrow Transplant; 2018 Feb; 53(2):146-154. PubMed ID: 29035394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous Graft-versus-Tumor Effect: Reality or Fiction?
    Porrata LF
    Adv Hematol; 2016; 2016():5385972. PubMed ID: 27635143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas.
    Merchant MS; Bernstein D; Amoako M; Baird K; Fleisher TA; Morre M; Steinberg SM; Sabatino M; Stroncek DF; Venkatasan AM; Wood BJ; Wright M; Zhang H; Mackall CL
    Clin Cancer Res; 2016 Jul; 22(13):3182-91. PubMed ID: 26823601
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.